This is to inform that due to some circumstances beyond the organizer control, “2nd Edition of International Conference on Gastroenterology” (Gastro 2024) during October 21-23, 2024 at Baltimore, MD, USA has been postponed. The updated dates and venue will be displayed shortly.
Your registration can be transferred to the next edition, if you have already confirmed your participation at the event.
For further details, please contact us at gastroenterology@magnusconference.com or call + 1 (702) 988-2320.
Hepatic encephalopathy (HE) is a neurological disorder that affects the brain as a result of liver failure or damage. It is characterized by an array of neurological symptoms, including confusion, difficulty concentrating, cognitive impairment, changes in sleep patterns, speech impairment, and changes in behavior. HE is caused by an accumulation of toxins in the body, usually due to liver failure or damage. When the liver fails to filter out toxins from the blood, they build up and can travel to the brain, resulting in neurological symptoms. In some cases, the accumulation of toxins can also cause abnormal levels of substances such as ammonia, which can lead to the development of HE. HE can be divided into two types: acute and chronic. Acute HE is usually caused by a sudden buildup of toxins in the body, such as after a period of alcohol abuse or a sudden infection. Chronic HE is caused by a long-term accumulation of toxins and is usually the result of liver cirrhosis or long-term alcohol abuse. Risk factors for HE include a history of alcohol abuse, cirrhosis, hepatitis, and other liver diseases.
Title : Novel exosomal biomarkers for MASH
Aleksandra Leszczynska, University of California San Diego, United States
Title : Validation of GLAS (GP73+LG2m+Age+Sex) and ASAP (Age+Sex+AFP+PIVKA-II) algorithms for the management of liver fibrosis, cirrhosis and cancer
Philip M Hemken, Abbott Diagnostics Division R&D, United States
Title : Reverse multiple myeloma: First hepatic amyloidosis then multiple myeloma
Milaris M Sanchez Cordero, Mayaguez Medical Center, Puerto Rico
Title : Autophagy promotes the survival of adipose mesenchymal stem/stromal cells and enhances their therapeutic effects in cisplatin-induced liver injury via modulating TGF-1/Smad and PI3K/AKT signaling pathways
Eman Mohamad EL Nashar, King Khalid University, Saudi Arabia
Title : Epigastric Impedance measures gastric malfunction non-invasively. Time to revive it
John Andrew Sutton, Gastria Ltd, United Kingdom
Title : Digesting the connection: Exploring the psychological impact of gastroenterology issues on mental and emotional well being
Tracy E Hill, MGS Products LLC, United States